Showing results (1251-1260 of 1,351) with videos related to
Sort By:
Pageof 136
Journal of Medicinal Chemistry|May 24, 2017
BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual ScreenAlex M Ayoub, Laura M L Hawk, Ryan J Herzig, et al.Nature|August 5, 2011
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaJohannes Zuber, Junwei Shi, Eric Wang, et al.BMC Cell Biology|March 21, 2013
BMSCs reduce rat granulosa cell apoptosis induced by cisplatin and perimenopauseJun-Qi Guo, Xia Gao, Zhi-Jie Lin, et al.Nature Communications|November 13, 2023
A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeuticsHyeong-Min Lee, William C Wright, Min Pan, et al.Nature Chemical Biology|March 7, 2018
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligandsLara N Gechijian, Dennis L Buckley, Matthew A Lawlor, et al.Protein & Cell|February 2, 2023
A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicron <i>in vivo</i>Daming Zuo, Yu Chen, Jian-Piao Cai, et al.Hepatology International|July 24, 2015
Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patientsJi-Dong Jia, Jin-Lin Hou, You-Kuan Yin, et al.European Journal of Medicinal Chemistry|September 28, 2024
Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent gluesMuhammad Murtaza Hassan, Yen-Der Li, Michelle W Ma, et al.Proceedings of the National Academy of Sciences of the United States of America|November 2, 2016
Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myelomaTeru Hideshima, Jun Qi, Ronald M Paranal, et al.Iscience|July 18, 2024
The efficacy of postoperative radiotherapy in resected pⅢA-N2 EGFR mutant and wild-type lung adenocarcinomaYue Zeng, Xing-Xiang Pu, Feng-Jiao He, et al.Pageof 136